- $6.55bn
- $7.44bn
- $1.94bn
- 72
- 57
- 20
- 48
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,162 | 1,285 | 1,898 | 1,692 | 1,941 |
Cost of Revenue | |||||
Gross Profit | 538 | 608 | 912 | 670 | 761 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 767 | 806 | 1,156 | 1,229 | 1,396 |
Operating Profit | 394 | 478 | 743 | 462 | 545 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 381 | 450 | 728 | 444 | 486 |
Provision for Income Taxes | |||||
Net Income After Taxes | 325 | 380 | 617 | 379 | 408 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 323 | 380 | 617 | 379 | 408 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 323 | 380 | 617 | 379 | 408 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.76 | 5.87 | 9.78 | 6.13 | 6.74 |
Dividends per Share |